ADVENT THERAPEUTICS INC

Lumberville, PA · Medtech · Still private

Aerosol formulation of vitamin A palmitate for inhaled delivery to preterm infants

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: Lumberville, PA
Total capital: $7.3M

Federal grants: $7.3M; 10 awards · 2018–2025; Rank in peer group#278 of 477
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 8 pending

Capital timeline

Latest events

Mar 2025Federal grantHealth and Human S · Phase II · Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation$993K
Mar 2024Federal grantHealth and Human S · Phase II · Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation$994K
Mar 2023Federal grantHealth and Human S · Phase II · Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation$995K
Mar 2023Federal grantHealth and Human S · Phase II · Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation$995K
Aug 2021Federal grantHealth and Human S · Phase II · Aerosolized Vitamin A: Impact on Neonatal Lung Maturation, Hyperoxic Lung Injury and Bronchopulmonary Dysplasia$1.3M
Aug 2020Federal grantHealth and Human S · Phase I · Advancing Small Molecule Read Through Compounds to Prevent and/or Treat Heritable Pulmonary Artery Hypertension$252K
Aug 2020Federal grantHealth and Human S · Phase I · Advancing Small Molecule Read Through Compounds to Prevent and/or Treat Heritable Pulmonary Artery Hypertension$252K

Show 3 earlier federal awards

Aug 2020Federal grantHealth and Human S · Phase II · Aerosolized Vitamin A: Impact on Neonatal Lung Maturation, Hyperoxic Lung Injury and Bronchopulmonary Dysplasia$1.1M
Jul 2018Federal grantHealth and Human S · Phase I · Aerosolized vitamin A impact on lung maturation and hyperoxic neonatal lung injury$225K
Jun 2018Federal grantHealth and Human S · Phase I · Aerosolized vitamin A impact on lung maturation and hyperoxic neonatal lung injury$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 8

Aug 31, 2023PendingPharmaceutical Compositions Comprising Insoluble Active IngredientsUSPTOApplication 18007589
Apr 6, 2023PendingCompositions Of Vitamin A Palmitate, Processes For Their Preparation, Uses And Methods Comprising ThemUSPTOApplication 17798874
PendingPharmaceutical Compositions Comprising Insoluble Active IngredientsUSPTOApplication PCTUS2021035210

Show all 8 patent records

Pharmaceutical Compositions Comprising Insoluble Active IngredientsAug 31, 2023 · Application 18007589Pending
Compositions Of Vitamin A Palmitate, Processes For Their Preparation, Uses And Methods Comprising ThemApr 6, 2023 · Application 17798874Pending
Pharmaceutical Compositions Comprising Insoluble Active IngredientsApplication PCTUS2021035210Pending
Compositions Of Vitamin A Palmitate, Processes For Their Preparation, Uses And Methods Comprising ThemApplication PCTUS2021015958Pending
Compositions of Vitamin AApplication 63069927Pending
Inhalable Vitamin A CompositionsApplication 63054425Pending
Inhalable Vitamin CompositionsApplication 63032768Pending
Compositions of Vitamin A Palmitate, Processes for Their Preparation, Uses and Methods Comprising ThemApplication 62972784Pending

BLOTTING INNOVATIONS, INCSimilar federal contract value in Medtech · null in contracts
NOCTURNAL PRODUCT DEVELOPMENT, LLCSimilar federal contract value in Medtech · null in contracts
CYTHORSimilar federal contract value in Medtech · null in contracts
CLOUDBREAK THERAPEUTICS LLCSimilar federal contract value in Medtech · null in contracts
NEUROSCOPE INC.Similar federal contract value in Medtech · null in contracts
AUGDIMER, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.